Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Cosmetic Specialty Labs warning letter

This article was originally published in The Rose Sheet

Executive Summary

Cosmetic Specialty Labs warning letter: Cites the Lawton, Okla.-based skin care manufacturer for violations of Good Manufacturing Practices regs. In a June 26 letter, FDA states that Cosmetic Specialty Labs has failed to conduct laboratory analysis of identity and strength of each product, document microbial analysis and conduct stability testing. The agency also notes the company lacks written procedures for a number of production steps...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts